MANNKIND CORP Capital Expenditures Incurred but Not yet Paid
MANNKIND CORP (MNKD) reported Capital Expenditures Incurred but Not yet Paid of -$177.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-05
- MANNKIND CORP capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$444.00K, a 518.87% decline year-over-year.
- MANNKIND CORP capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $267.00K, a 85.42% increase year-over-year.
- MANNKIND CORP capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$206.00K, a 206.74% decline year-over-year.
- MANNKIND CORP capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $575.00K, a 601.22% increase year-over-year.
- MANNKIND CORP capital expenditures incurred but not yet paid for fiscal 2025 was $619.00K, a 63.13% decline from fiscal 2024.
- MANNKIND CORP capital expenditures incurred but not yet paid for fiscal 2024 was $1.68M, a 0.71% decline from fiscal 2023.
- MANNKIND CORP capital expenditures incurred but not yet paid for fiscal 2023 was $1.69M, a 30.28% increase from fiscal 2022.
- MANNKIND CORP capital expenditures incurred but not yet paid for fiscal 2022 was $1.30M, a 2.69% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$444.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$177.00K 10-Q · filed 2026-08-05 | -$383.00K derived: sum of 3 quarters · filed 2026-08-05 | $192.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $267.00K 10-Q · filed 2026-05-06 | $61.00K derived: sum of 2 quarters · filed 2026-05-06 | $636.00K derived: sum of 3 quarters · filed 2026-05-06 | $742.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $369.00K derived: sum of 2 quarters · filed 2026-02-26 | $475.00K derived: sum of 3 quarters · filed 2026-08-05 | $619.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $575.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $681.00K derived: sum of 2 quarters · filed 2026-08-05 | $825.00K 10-Q · filed 2025-11-05 | $1.02M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $250.00K 10-Q · filed 2026-08-05 | $443.00K derived: sum of 3 quarters · filed 2026-08-05 | $525.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $144.00K 10-Q · filed 2026-05-06 | $337.00K derived: sum of 2 quarters · filed 2026-05-06 | $419.00K derived: sum of 3 quarters · filed 2026-05-06 | $156.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $275.00K derived: sum of 2 quarters · filed 2026-02-26 | $12.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.68M 10-K · filed 2026-02-26 |
| 2024-09-30 | $82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$181.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.49M 10-Q · filed 2025-11-05 | $687.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$263.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.40M 10-Q · filed 2025-08-06 | $605.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.24M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.67M 10-Q · filed 2025-05-08 | $868.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.50M derived: sum of 3 quarters · filed 2026-02-26 | $920.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$799.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$167.00K derived: sum of 2 quarters · filed 2026-02-26 | -$747.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.69M 10-K · filed 2026-02-26 |
| 2023-09-30 | $632.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $52.00K derived: sum of 2 quarters · filed 2024-11-07 | $2.49M 10-Q · filed 2024-11-07 | $2.35M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | -$580.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.86M 10-Q · filed 2024-08-07 | $1.72M derived: sum of 3 quarters · filed 2025-02-26 | $2.24M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $2.44M 10-Q · filed 2024-05-08 | $2.30M derived: sum of 2 quarters · filed 2025-02-26 | $2.82M derived: sum of 3 quarters · filed 2025-02-26 | $3.35M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $382.00K derived: sum of 2 quarters · filed 2025-02-26 | $915.00K derived: sum of 3 quarters · filed 2025-02-26 | $1.30M 10-K · filed 2025-02-26 |
| 2022-09-30 | $517.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.05M derived: sum of 2 quarters · filed 2023-11-07 | $1.43M 10-Q · filed 2023-11-07 | $2.54M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $533.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $916.00K 10-Q · filed 2023-08-07 | $2.03M derived: sum of 3 quarters · filed 2024-02-27 | $997.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $383.00K 10-Q · filed 2023-05-09 | $1.49M derived: sum of 2 quarters · filed 2024-02-27 | $464.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.52M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $81.00K derived: sum of 2 quarters · filed 2024-02-27 | $1.14M derived: sum of 3 quarters · filed 2024-02-27 | $1.26M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $30.00K derived: sum of 2 quarters · filed 2022-11-08 | $154.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.18M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $124.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $92.00K 10-K · filed 2023-02-23 | |||
| 2020-03-31 | $32.00K 10-Q · filed 2021-05-12 | |||
| 2019-09-30 | -$587.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$43.00K derived: sum of 2 quarters · filed 2020-11-04 | $203.00K 10-Q · filed 2020-11-04 | |
| 2019-06-30 | $544.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $790.00K 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $246.00K 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |